Screener
Haemonetics HAE Business Segments
| Q1 '27 | Q3 '26 | Q2 '26 | Q1 '26 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| Net revenues by Business | ||||||
| Apheresis | $191.32M+5.3% | —— | —— | $181.74M— | —— | |
| MedSurg | $148.06M+6.0% | —— | —— | $139.66M— | —— | |
| Net revenues by Product | ||||||
| Blood Management Technologies | $88.12M+8.6% | —— | —— | $81.18M— | —— | |
| Interventional Technologies | $59.94M+2.5% | —— | —— | $58.48M— | —— | |
| Revenue by Geography | ||||||
| Europe | $45.53M+11.4% | $48.28M+9.3% | $42.97M+2.3% | $40.88M-13.4% | $44.16M+19.2% | |
| Japan | $12.86M-5.8% | $18.14M+12.1% | $18.01M+9.7% | $13.65M-0.4% | $16.17M+9.1% | |
| Other | $2.99M+6.2% | $1.81M-63.3% | $3.68M-30.1% | $2.81M-57.1% | $4.94M+86.5% | |
| UNITED STATES | $257.84M+6.4% | $247.71M-3.9% | $240.09M-6.2% | $242.4M-2.6% | $257.67M+2.7% |
FAQ
- How does Haemonetics break its business down?
- Haemonetics (HAE) reports net revenues by business across 2 parts — Apheresis and MedSurg. Each is extracted from the segment footnotes and tracked over time.
- Where does Haemonetics's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Haemonetics's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
